Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing

A method for improving wound healing in a mammal, the method comprising:

• identifying a mammal suffering from or at risk of suffering from wounds:
• and
• administering an effective amount of two or more of the following substances:
• berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll, vitamin C, and aloe vera, wherein the administering improves wound healing.

A method for improving the innervation of regenerating tissue in a mammal, the method comprising:

• identifying a mammal suffering from or at risk of suffering from a lack of innervation of regenerating tissue;
• and
• administering an effective amount of two or more of the following substances:
• berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll vitamin C, and aloe vera, wherein the administering improves the innervation of regenerating tissue.

A method for improving the healing of excisional dermal wounds in a mammal, the method comprising:

• identifying a mammal suffering from or at risk of suffering from excisional dermal wounds;
• and
• administering an effective amount of two or more of the following substances:
• berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll, vitamin C, and aloe vera, wherein the administering improves healing of the excisional dermal wounds.

A method for improving peripheral circulation in a mammal, the method comprising:

• identifying a mammal suffering from or at risk of suffering from poor peripheral circulation;
• and
• administering an effective amount of two or more of the following substances:
• berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll, vitamin C, and aloe vera, wherein the administering improves the peripheral circulation.

A method for preventing or healing neurodegeneration in a mammal, the method comprising:

• identifying a mammal suffering from or at risk of suffering from neurodegeneration;
• and
• administering an effective amount of two or more of the following substances:
• berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll, vitamin C, and aloe vera, wherein the administering prevents or heals the neurodegeneration.

A composition for administration to reduce inflammation and enhance wound healing in a mammal, the composition comprising:

• an amount of berry extract between:
• a lower limit of approximately 3 mg human equivalency dosage (HED) per day;
• and
• an upper limit of approximately 500 mg HED per day;
• an amount of chromium between:
• a lower limit of approximately 10 μg HED per day;
• and
• an upper limit of approximately 1000 μg HED per day;
• an amount of zinc between:
• a lower limit of approximately 1.5 mg HED per day;
• and
• an upper limit of approximately 75 mg HED per day;
• an amount of trans-resveratrol between:
• a lower limit of approximately 0.1 mg HED per day;
• and
• an upper limit of approximately 50 mg HED per day;
• an amount of l-arginine between:
• a lower limit of approximately 50 mg HED per day;
• and
• an upper limit of approximately 5000 mg HED per day;
• an amount of chlorophyllin between:
• a lower limit of approximately 10 mg HED per day;
• and
• an upper limit of approximately 300 mg HED per day.
• an amount of vitamin C between:
• a lower limit of approximately 10 mg HED per day;
• and
• an upper limit of approximately 10,000 mg HED per day.